Synthesis of full-gene-length transcripts from the majority of protein-coding genes is not the default process in metazoans; rather, it depends on the suppression of PCPA from cryptic polyadenylation signals (PASs) in nascent transcripts 1, 2 . Although PASs at the 3′ ends of genes are most commonly used 3 , previous experiments have shown that blocking the 5′-end sequence of U1 using an antisense morpholino oligonucleotide (AMO) causes widespread PCPA from cryptic PASs in nascent RNA polymerase II (pol II) transcripts in metazoan cells 1,2 . This functional U1 inhibition revealed an additional role for U1, previously known for its role in precursor-mRNA (pre-mRNA) splicing 4 . We have termed this PCPA-suppression activity 'telescripting' to indicate that it is required for full-gene-length transcription. Similar to U1's function in 5′-splice-site recognition, which is the first step in splicing, telescripting also depends on the base-pairing of the 5′-end sequence of U1 with pre-mRNAs. We have shown that the range of U1 telescripting is limited to about 1 kb, suggesting that U1 bound to the 5′ splice site for splicing might be insufficient to protect large (multi-kilobase) introns that are common in vertebrates. A model to address this limitation proposed that U1 would also bind extensively in introns, explaining U1's abundance and known base pairing degeneracy. This model has recently been supported by the cross-linking of U1 to introns 5 . The model also proposed that PCPA and telescripting occur cotranscriptionally, but this has not yet been tested directly. U1's role in nascent transcriptome protection has also recently been found to extend to upstream antisense transcripts (uaRNAs/PROMPTs), thus leading to the important observation that a high ratio of PAS to U1-binding sites in the antisense direction of divergent pol II promoters reinforces transcription in the protein-coding sense direction 6, 7 .
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Information about telescripting has thus far been limited by the moderate resolution of the methodologies used, including genomic tiling arrays 1 and the subtractive hybridization-based HIDE-seq 2 . Importantly, these studies have not elucidated the potential role of U1 telescripting in gene expression regulation. Here, we applied RNA sequencing (RNA-seq) to obtain high-definition genome-wide characterization of PCPA and U1 telescripting and used pol II chromatin immunoprecipitation and sequencing (ChIP-seq) to determine U1's role in transcription.
RESULTS

Gene-specific variations in U1 telescripting dependence
We used metabolic 30-min pulse labeling using 4-thiouridine (4-shU) [8] [9] [10] to enhance detection of the effects of U1 inhibition on nascent transcripts and mRNA synthesis in HeLa cells. 4-shU labeling was carried out at 3.5 and 7.5 h post transfection (hereafter referred to 4-and 8-h transfection, respectively) with the same dose of either U1 AMO or control, nontargeting AMO. All RNAs transcribed during the labeling time window incorporate 4-shU and thus were able to be purified by a two-cycle thiol affinity selection under stringent conditions ( Supplementary Fig. 1a,b) . RNA-seq of these purified RNAs yielded 43-167 million mapped reads per sample (Supplementary Table 1 ). All samples were normalized to the same sequencing depth 1 Howard Hughes Medical Institute, Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. 2 These authors contributed equally to this work. Correspondence should be addressed to G.D. (gdreyfuss@hhmi.upenn.edu).
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VOLUME 24 NUMBER 11 NOVEMBER 2017 nature structural & molecular biology a r t i c l e s (RPM, reads per million). Parsing the RNA-seq reads showed that U1 AMO treatment decreased the total number of spliced junctions by 40% and changed the overall distribution of reads in genes, decreasing exon reads from 43% to 30% and increasing intron reads from 57% to 70% (Supplementary Fig. 1c-e) . However, genome browser views of mapped reads in thousands of genes showed that these changes in RNA-seq reads with U1 AMO were generally not distributed uniformly throughout a gene and were inconsistent with intron retention (Fig. 1) . The most common change observed with U1 AMO treatment, illustrated in representative genome browser views (Fig. 1) , was the appearance of prominent peaks accumulating at the 5′ end of genes, extending from the transcription start site (TSS) and ending in one of the first introns (Fig. 1) . These endpoints contained nongenomic 3′-poly(A) reads, indicating that they were produced by PCPA. Downstream of the PCPA points there was a clear reduction, and sometimes complete elimination, of reads, including in exons and the 3′ UTR. Genome browser views of representative mapped RNA-seq reads in several genes are shown in Figure 1 .
The 3′-poly(A) nature of prematurely cleaved and polyadenylated (PCPAed) transcripts was further validated using 3′ rapid amplification of cDNA ends (3′ RACE) in select genes ( Supplementary  Fig. 2a) . Frequently, multiple 3′-poly(A) peaks were detected in the same gene, including closely spaced series in the same intron, suggesting that multiple PASs can be actionable and full-length transcripts require U1 telescripting of all PASs (Fig. 1) . Binding of cleavage and polyadenylation factors, such as CstF64, at or near PCPA locations in normal HeLa cells 11 supports this conclusion and shows that these actionable PASs are indistinguishable from those found at the ends of full-length transcripts (Fig. 1, CstF64 iCLIP) . Furthermore, as discussed below, many PCPA locations coincided with 3′-poly(A) reads that were previously detected in human tissues (Fig. 1 , tissue poly(A) tracks) 12 .
PCPA susceptibility increases with gene size
To estimate the global scope of PCPA, we implemented a computational workflow to identify genes with the characteristic RNA-seq pattern changes in U1 AMO versus control AMO as described: a significant decrease in reads in the last exon compared to the first exon (≥2-fold, P value ≤ 0.01, Poisson test) and a significant increase in reads in the first quarter compared to the last quarter of the premRNA between the first 5′splice site and the last 3′splice site (P value ≤ 0.01, Poisson test). This scheme captures both single-point and complete PCPA, such as those exemplified in Figure 1 , as well as partial and multipoint PCPA anywhere throughout the pre-mRNA (for example ARID1B and ABCC1, Supplementary Fig. 2b ). It excludes transcription initiation downregulation, which would decrease reads throughout the transcript. The PCPA calculation was applied to the longest isoform (RefSeq) of all intron-containing expressed genes (n = 9,744, reads per million mapped reads (RPKM) ≥ 1) from the 8-h data set and identified 3,590 genes as PCPAed. Visual inspection of hundreds of genes confirmed the validity of this analysis. Nearly 90% of genes detected as PCPAed in the 4-h experiment were also called as PCPAed at 8 h post U1 AMO transfection ( Supplementary  Fig. 2c,d and Supplementary Table 2), suggesting rapid onset and nearly complete effectiveness for the transfected U1 AMO dose.
Comparison of PCPAed and non-PCPAed genes revealed a striking difference in gene size (Fig. 2a) . The median size of PCPAed genes was 39.0 kb, much larger than the median size of all expressed genes, 22.8 kb, whereas the median size of genes that were not PCPAed was 14.2 kb. Human gene size is highly correlated with intron size in general, as shown for all expressed genes in our samples (R 2 = 0.9994; Supplementary Fig. 2e ). Intron number also increases with gene size; however, PCPA frequently occurred in the first or second introns (38%; see below), which in mammals are typically the largest 13 . Thus, increased PCPA susceptibility of large genes derives predominantly from the length rather than the number of the introns.
As expected, full-length mRNA production from PCPAed genes decreased ( Fig. 2b and Supplementary Fig. 2d) ; however, numerous non-PCPAed genes were not downregulated and their transcripts continued to splice efficiently, for example GAPDH and RPL19 (Supplementary Fig. 3a,b) . Importantly, many non-PCPAed genes (n = 988; median 6.8 kb) were upregulated in U1-inhibited cells (Fig. 2) . Increased mRNA production and protein productivity of these upregulated genes, such as MYC, CYR61, ADAMTS1 and GADD45B, in U1 AMO-treated cells was confirmed by RT-qPCR and western blot ( Fig. 3 and Supplementary Fig. 3c-e) . The RT-qPCR, which included ERCC RNA spike-in controls for normalization of input RNA amount, confirmed the RNA-seq data, showing that the absolute levels of GAPDH and RPL19 mRNAs did not change after U1 AMO treatment, whereas levels of MYC, CYR61, ADAMTS1 and GADD45B mRNAs increased several fold and the transcript levels of select PCPAed genes decreased ( Supplementary Fig. 3c-e) . The increases in mRNA productivity were particularly striking, considering that the strong U1 inhibition was sufficient to PCPA nearly half of the expressed genes. There was no detectable PCPA in intronless genes a r t i c l e s (median 1.3 kb), which can be explained by the lower probability of a PAS arising stochastically in small genes ( Supplementary Fig. 3f ). Consistent with the established role of U1 in splicing, there was a 40% overall decrease in spliced exon-exon junctions ( Supplementary  Fig. 1d ) upon U1 inhibition. However, as shown in Figure 1 , much of the decrease could be the result of the loss of transcription of exons downstream of PCPA points rather than splicing inhibition. Analysis of spliced exon-exon junctions showed that splicing decreased by 71% in PCPAed genes but only 26% in non-PCPAed genes. Except for genes in which PCPA occurred in the first intron, splicing inhibition (intron retention) was also evident upstream of PCPA points ( Supplementary  Fig. 2b ). However, non-PCPAed genes showed a moderate decrease in exon-exon junctions occurring uniformly throughout the gene, and PCPAed genes had greater loss of exon-exon junctions at their 3′ ends, thus supporting the conclusion that a major fraction of the splicing decrease in U1 AMO cells is an indirect effect of loss of telescripting ( Supplementary Fig. 4 ). Analysis of de novo-spliced reads showed a detectable increase in usage of unannotated splice sites and alternative splicing changes; however, the vast majority of splicing remained from the same previously annotated splice sites despite U1 inhibition ( Supplementary Fig. 1e and Supplementary Table 3 ).
U1 inhibition prematurely terminates elongating pol II in gene bodies
To investigate the relationship between PCPA and pol II transcription, we performed ChIP-seq with an antibody that recognizes the N terminus of pol II. Representative patterns showed that pol II signals tracked with RNA from the TSS up to the canonical 3′ end of genes and decreased to background level within a few kb downstream of the 3′ end in control cells (Fig. 4a) . This observation of the termination zone (TZ) is consistent with the torpedo termination model [14] [15] [16] . U1 AMO reduced pol II signal downstream of the PCPA site, whereas pol II signal from the TSS to the PCPA site remained largely unaffected. A similar pattern of pol II TZs across several kilobases past the PCPA point in gene bodies indicates that the termination mechanism at the PCPA site is the same as that of the PASs at the 3′ ends of genes. In many cases, the pol II density was markedly higher than in these same regions in the control, suggesting that transcription initiation was not inhibited and could, in some cases, be increased.
By contrast, in small genes that showed increased mRNA productivity (n = 988; median 6.8 kb), such as MYC and CYR61, pol II peak heights and density were much higher with U1 AMO treatment (Fig. 3a) . Pol II density increases indicate higher transcription flux, which were also observed in many PCPAed genes up to the PCPA point (Fig. 4a) .
Pol II metagene plots of PCPAed genes ( Fig. 4b) indicated the generality of these observations. It showed that the prominent promoter-proximal paused pol II peak (~200 bp) downstream of the sense-direction TSS was relatively unchanged, indicating that transcription initiation was not inhibited by U1 inhibition. Importantly, Fig. 4b ). The pol II signal upstream of the TSS, which represents upstream antisense transcription (uaRNAs/PROMPTs) 6, 7 , was clearly decreased. RNA-seq data also showed clear PCPA in the antisense direction ( Supplementary Fig. 5a ), consistent with the previously described role of U1 in the bidirectional regulation of transcription from divergent promoters 6, 7 . These data demonstrate that loss of telescripting cotranscriptionally terminated elongating polymerases prematurely in gene bodies. Pol II metagene plots for all expressed genes showed a similar pattern, indicating the impact of strong U1 inhibition on transcription throughout the genome ( Supplementary  Fig. 5b ). TSS-proximal pol II peaks in upregulated, non-PCPAed genes increased nearly two-fold, suggesting that transcription initiation was not totally impaired.
Naturally occurring PCPA in normal human tissues causes transcription attrition in large genes
We analyzed publicly available data sets of 3′-poly(A)-seq generated by means of dedicated poly(A)-seq methodology of several human tissues, without deliberate U1 inhibition 12 . This analysis showed widespread usage of PASs in gene bodies under normal conditions (Figs. 1, 5a; tissue poly(A)). In many cases, U1 AMO-induced PCPA sites coincided with 3′-poly(A) locations detected in vivo (Fig. 5a) . For example, in E2F3, PCPA was evident in normal tissues at the strongest CstF64-marked site in intron 1, which became more prominent with U1 AMO treatment. In other genes, such as EXT1, U1 AMO induced PCPA more proximal to the TSS, potentially from a PAS that is normally more strongly telescripted (Fig. 5a) . Metagene analysis showed high coincidence of 3′-poly(A) reads in gene bodies in normal human tissues and those induced by U1 AMO in HeLa cells, suggesting that the in vivo 3′ poly(A)s are also related to U1 telescripting loss (Fig. 5b) . Metagene plots confirmed the generality of CstF64-binding sites near U1 AMO-induced 3′-poly(A) reads (Figs. 1, 5c) . The trend toward utilization of more TSS-proximal PASs with U1 AMO compared to normal tissues (Fig. 5d) is consistent with that of a cotranscriptional process 2 , in the 5′-to-3′ direction, as also demonstrated by the pol II ChIP-seq data (Fig. 4) .
Genome browser views showed that some of the 3′ poly(A)s in introns in normal tissues corresponded to the ends of previously detected shorter, spliced isoforms (Supplementary Fig. 6a ). These 3′ poly(A)s can be considered alternative polyadenylation, or PCPA (relative to the full-length) that generates alternative mRNA isoforms encoding proteins with shorter or alternative C termini (for example, homer-1, dab-1 (ref.
2) and EGFR 17 ). However, most PCPAs did not appear to produce stable RNAs (Supplementary Fig. 6a ) but nevertheless decreased the fraction of polymerases that transcribe to full length. We refer to this widespread physiological phenomenon as transcription attrition. We calculated the ratio of 3′-poly(A) reads in the last exon versus the gene body from the Derti et al. 12 data sets to estimate the fraction of polymerases that transcribed and polyadenylated near the gene's longest isoform (Fig. 5e and Supplementary  Table 4 ). These ratios are rough estimates, because the various 3′-polyadenylated RNAs from the same gene can have different stabilities; nevertheless, a plot of each gene's ratio versus its size clearly showed that large genes are highly susceptible to transcription attrition in human tissues ( Fig. 5e and Supplementary Fig. 6b) . Examples of genes with low ratios (Supplementary Fig. 6a ) illustrate how transcription attrition can severely reduce full-length transcription. These observations suggest that at baseline, many large genes' transcripts experience incomplete U1 telescripting and can potentially be shut off if the balance between U1 telescripting and PCPA shifts in favor of the latter (Supplementary Fig. 6a,c) .
Gene size-function relationship
The above analyses revealed two groups of genes of particular interest in terms of full-length mRNA productivity in U1 AMO-transfected cells: genes that are PCPAed, which as a result are downregulated, and non-PCPAed and upregulated genes, which are both telescripting independent and have the ability to splice in a U1-deficient environment. Gene ontology (GO) enrichment analysis 18, 19 showed differential enrichment in functions encoded by these two gene groups (Fig. 6a,b and Supplementary Table 5) . Upregulated, non-PCPAed Figure 2 (n = 3,590), with control (black) or U1 AMO (red), relative to the TSS (−1,000 bp to +500 bp) and TES regions (transcription end site; 500 bp upstream of the annotated mRNA 3′ ends and 1,000 bp downstream). Regions between TSS + 500 bp and TES − 500 bp of each gene body were scaled to 2 kb.
a r t i c l e s genes were enriched in functions related to cell-stress response and growth-inducing stimuli, including numerous transcription, splicing, translation and signaling factors. PCPAed genes encoded diverse functions, as expected from the large number of genes in this group, but they were highly enriched in functions related to DNA replication and repair, cell cycle progression, including mitotic spindle formation, and intracellular organization and transport. PCPAed genes were also enriched for processes related to development, such as neural tube closure. These data suggest that the functions of small, PCPA-resistant, upregulated genes are particularly important for cells' acute response to stimuli and adaptation to adverse environmental changes, during which the mRNA productivity of PCPAed genes is apparently more dispensable.
Extending the analysis to all human genes (many of which are not expressed in HeLa cells) categorized by the same GO terms as those enriched in either group suggested a gene size-function relationship. Generally, functions related to cell survival and response to acute adverse stimuli were over-represented in small genes but under-represented in very large genes, whereas cell-division-and tissue-differentiation-related functions showed the opposite (Fig. 6c) . Small and U1 AMO-upregulated genes are also more ubiquitously expressed, whereas large genes are more tissue-specific and typically expressed in differentiated cells 20, 21 .
Comparison of orthologous genes in several metazoans showed that orthologs of the non-PCPAed genes that are upregulated with U1 AMO are consistently smaller than orthologs of PCPAed genes. Interestingly, the size gap between these gene groups progressively increased, especially in vertebrates (fish to human; Fig. 6d) . However, the widening gene-size differential between the two groups could not be explained by the more moderate increase in intron (or exon) number (Fig. 6e) . Calculating the ratio of intron-versus-exon length for the orthologs of the two groups in each of these organisms showed a much greater intron size expansion in PCPAed genes compared to non-PCPAed genes and upregulated genes (Supplementary Table 6 ). Thus, intron size expansion in the evolution of vertebrates a r t i c l e s was a primary factor in making their genomes' size-function stratification progressively more polarized.
DISCUSSION
Our studies here show that U1 is required for selectively telescripting large introns, where it protects pol II from prematurely terminating in gene bodies. U1 telescripting averts PCPA cotranscriptionally, as originally proposed 2 , thus ruling out an alternative mechanism whereby the PCPA products are derived post-transcriptionally from full-length mRNA. Telescripting is thus crucial for long-range transcription elongation, and our data show that pol II termination is coupled to 3′-end cleavage wherever it occurs. PCPA points, numerous in large genes, are therefore transcription-elongation checkpoints. Traversing them depends on sufficient U1 and other factors that may play a role in telescripting. We have previously described that acute transcription upregulation can transiently create a relative U1 shortage without decreasing the U1 level in absolute terms. For example, membrane depolarization in neuronal-type cells rapidly increases overall transcription, leading to PCPA in introns of synaptogenesis genes like homer-1, thereby converting them to a shorter isoform with the opposite function to that of the full-length isoform. This switch can be antagonized by U1 overexpression and can be recapitulated by lowlevel U1 AMO 2 . Our studies show that PCPA occurs in normal tissues in humans and other organisms, indicating that it is an omnipresent barrier to full-length transcription and causes transcription attrition in thousands of genes. U1 AMO thus recapitulates and exacerbates an important physiological phenomenon and provides an experimental tool for systematically studying it.
Although not previously tested in human cells, the general splicing reduction effected by U1 inhibition was expected. However, full-length mRNA downregulation from large genes was primarily due to loss of telescripting rather than loss of splicing, because U1 inhibition terminated transcription in many large introns well before reaching the 3′ splice site (Fig. 1) . Moreover, a significant portion of splicing loss was actually due to the elimination of splicing opportunities secondary to PCPA in an upstream intron. Thus, loss of splicing from lower available U1 overestimates U1's direct role in splicing. PCPA, however, is not a secondary effect of splicing inhibition; it typically occurs at great distances upstream of the 3′splice site and is not elicited by other splicing inhibition (spliceostatin A or U2 AMO 1 and Supplementary Fig. 7) .
Compared to the strong effect of U1 inhibition on telescripting, U1's well-established function in splicing was surprisingly robust in the same environment. It is possible that the residual uninhibited U1 pool is sufficient to sustain nearly normal splicing output. However, it is also possible that many small introns can splice with very little U1 or with none at all. Previous studies, albeit for only a handful of small introns in vitro, have shown that splicing can take place in U1-depleted cell extracts if the extracts are supplemented with excess SR proteins, a splicing-active group of hnRNP proteins [22] [23] [24] . PCPA could mimic these conditions by decreasing the number of introns that compete for the same factors.
Telescripting is an unprecedented gene regulation mechanism as it discriminates genes according to their size. The selective dependence of large nascent transcripts on telescripting stems from their long introns, which stochastically contain more PASs. This dependence in itself makes large pre-mRNAs more vulnerable to relative U1 telescripting shortage, which can be triggered by transcription upregulation 2 . However, the ability of many small genes to increase their spliced mRNA productivity in the same environment appears paradoxical. There are several potential and non-mutually-exclusive explanations for the upregulation of these small genes, including that U1 inhibition may generate a stress signal that activates their transcription or that PCPA knocks down factors that negatively regulate their transcription. It is also possible that, by truncating large nascent transcripts, PCPA decreases competition for transcription and other pre-mRNA-processing factors that small genes can use to boost their expression. Studies in divergent eukaryotes have shown that competition between pre-mRNAs for a variety of factors, likely minor compared to what PCPA can bring about, has a strong impact on mRNA synthesis from many genes 2, [25] [26] [27] [28] [29] . Future studies will address these mechanisms.
The functions encoded by the small genes that are upregulated with U1 AMO add an important perspective. This group is ubiquitously expressed and enriched in primary-response genes that are induced during acute cell stimulation and are necessary to adapt to adverse environmental changes and stressors. Such functions are under-represented a r t i c l e s in large PCPAed genes, which are more diverse and generally expressed in differentiated tissues. Notable among the largest genes are neuronal and developmental genes 20, 21 , which given their size would probably be highly susceptible to PCPA and could be transiently sacrificed to enhance expression of genes advantageous for cell survival, though potentially impair the organism. In addition to a shorter transcription time, PCPA avoidance probably played a role in selection against intron expansion in genes that are crucial for enhancing cell survival prospects under adverse circumstances. The scarcity of such functions among very large genes suggests that the massive intron expansion paralleled the evolution of complex organisms [30] [31] [32] and was not random but rather was selected against in such genes but permitted in others. Indeed, examination of orthologous genes in several other organisms showed that sizes of PCPAed genes increased progressively much more than those of small genes that were more refractory to U1 inhibition (Fig. 6d) . The increased intron size expansion in the evolution of vertebrates, especially in mammals, suggests that a greater polarization in the sizes and functions of genes was not merely tolerated but was increasingly adopted outside of essential survival genes, suggesting that it was advantageous. The U1-inhibition experiments reveal that one such advantage of a polarized genome is that it adds a new layer of global gene-expression control. Another hitherto unexplained aspect of intron expansion is its positional bias within genes. In humans, the first or second introns are typically the largest 13 , extending well beyond the first quarter of the gene, where PCPA frequently occurred, followed by a cluster of smaller introns and exons. This architecture seems to be geared to maximize loss of competition for splicing resources by PCPA and potential gain for non-PCPAed genes, providing an attractive rationale for TSS-proximal intron expansion.
METhODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. pol II (or control IgG) antibody (Santa Cruz, sc-899 X) overnight. For IP, an antibody to pol II's N-terminal domain was used to detect all pol II molecules on actively transcribed genes regardless of its C-terminal domain's phosphorylation state, which could vary throughout a gene. Beads were washed extensively, then formaldehyde cross-linking was reversed overnight at 65 °C in the presence of 1% SDS and RNase A. Proteins were digested for 2 h, then DNA was extracted twice with phenol-chloroform-isoamyl alcohol and ethanol/NaCl precipitation. The DNA (5-10 ng) was used to make libraries for ChIP-seq using the Truseq ChIP kit (Illumina) according to manufacturer recommendations. Four samples were pooled and sequenced on Illumina 2000 platform (50-bp single-end sequencing). After sequencing and alignment, the background and nonspecific binding was removed for the experimental samples using the model-based analysis of ChIPSeq (MACS) algorithm 41 . This program was also used to output BedGraph files for visualization on the UCSC genome browser.
Immunoblot analysis. HeLa cells transfected with control AMO, different U1 AMO doses (1, 15 and 50 nmol), 50 nmol of U2 AMO, 5 nmol of U6 AMO or 15 nmol of U12 AMO for 8 h and total cell extract were used for western blot analysis. The antibodies were specific to the CYR61 (Santa Cruz, sc-13100), cMyc (Abcam, ab32072) and Magoh (Dreyfuss lab) 42 .
Gene size-function analysis. We used XGR GO term analysis (http:// galahad.well.ox.ac.uk:3020) 18 to classify genes into different functional categories (Supplementary Table 5 ) with the following criteria: (a) 10 as minimum number of genes annotated, (b) 2,000 as maximum number of genes annotated, (c) 5 as minimum overlap with your input genes, then used REVIGO (http://revigo.irb.hr) 19 to summarize the long list of GO terms into a histogram (Fig. 6a,b) . The number of PCPAed downregulated genes or non-PCPAed upregulated genes annotated to each GO term were summed and a Fisher's exact test was used to check if the number of genes in the former group was significantly (P value < 0.05) higher than the latter or vice versa. To extend this analysis globally to the human genome, the median gene length was calculated for each significantly enriched GO term using all genes classified in the group from XGR, not just those expressed in HeLa, and the distribution was shown by boxplot (Fig. 6c) .
Orthologs and all related information were taken from Ensembl's Biomart (http://www.ensembl.org/) 33 . Nonhuman species were compared against the human genes for orthologs.
Code availability. Code for the analyses described in this study is available from the corresponding author upon request.
Data availability. All sequencing data described are available on GEO under the accession number GSE103252. A Life Sciences Reporting Summary for this article is available.
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Describe how sample size was determined.
To run a two-tailed Student's t-test, we needed at least 3 repeats for each experiment.
Data exclusions
Describe any data exclusions. There is no data exclusions.
Replication
Describe whether the experimental findings were reliably reproduced.
We repeated at least 3 times for real-time PCR and Western blot analysis.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
We randomly selected cells for each control or U1 AMO transfection.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
We were not blinded to the experimental groups during the analysis, however data assessment was conducted in a blinded fashion.
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The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
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